• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1998 Fiscal Year Final Research Report Summary

Basic Research for The Immuno-genetherapy of Brain Tumors

Research Project

Project/Area Number 09671409
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Cerebral neurosurgery
Research InstitutionCHIBA UNIVERSITY

Principal Investigator

IWADATE Yasuo  CHIBA UNIVARSITY,NEUROSURGERY,ASSISTANT, 医学部, 助手 (70272309)

Co-Investigator(Kenkyū-buntansha) YAMAURA Akira  CHIBA UNIVERSITY,NEUROSURGERY,PROFESSOR, 医学部, 教授 (40009717)
NAMBA Hiroki  CHIBA CANCER CENTER,NEURISURGERY, 医長
TAGAWA Masatoshi  CHIBA CANCER CENTER,PATHOLOGY, 研究局, 部長
Project Period (FY) 1997 – 1998
Keywordsgene therapy / brain tumor / interleukin-2 / immunity
Research Abstract

Enhancement of host antitumor response using cytokine-producing tumor cells has been investigated in various types of cancers. The central nervous system, however, shows tolerance for activated immune reactions, and this relative unresponsiveness may lessen the efficacy of immunotherapy for brain tumors. Using interleukin-2 (IL-2)-producing 9L rat gliosarcoma cells (9L/IL-2), we examined whether secretion of IL-2 from subcutaneous (s.c.) and/or intracranial (i.c.) tumors can elicit augmented immunological response to brain tumors. Syngeneic rats could reject 9L/IL-2 cells inoculated s.c., but developed i.c. 9L/IL-2 tumors. The growth of i.c. 9L/IL-2 tumors was, however, significantly retarded compared with that of wild-type tumors. The growth of i.c. wild-type tumors was also suppressed, when the rats concurrently received 9L/IL-2 cells s.c.. Moreover, most of the rats which inoculated i.c. with 9L/IL-2 cells did not developed brain tumors, when concurrently injected s.c. with 9L/IL-2 cells. Immunohistochemical analysis revealed that migration of CD4- positive T cells, CD8-positive T cells, monocytes/ microglias and macrophages in i.c. 9L/IL-2 tumors was less notable than that in s.c. 9L/IL-2 tumors, but was more significant than that in i.c. wild-type tumors. When the rats were inoculated s.c. with 9L/IL-2 cells, the cellular infiltration into intracranial 9L/IL-2 tumors was markedly augmented to a similar level as found in s.c. 9L/IL-2 tumors. The present study may raise a possibility of a therapeutic strategy for brain tumors by the combinatory expression of IL-2 gene using s.c. immunization followed by the direct gene transfer into brain tumors.

  • Research Products

    (5 results)

All Other

All Publications (5 results)

  • [Publications] Y.Iwadate, et al: "In vivo bystander effect in the intracranial model with rat glioma cells reflecte the clonal difference of HSV-TK positive cells" Int J Oncology. 9. 521-525 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Y.Iwadate,et al.: "Induction of acquired immunity in rats that have eliminated intracranial gliosarcoma cells by the expression of herpes simplex virus-thymidine kinase gene and ganciclovir administration." Oncology. 54. 329-334 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 岩立康男、他: "サイトカイン遺伝子導入による脳腫瘍の獲得免疫誘導能" 神経免疫研究. 10. 65-70 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Iwadate, Y., Namba, H., Tagawa, M., Takenaga, K., Sueyoshi., Sakiyama, S.: "Induction of acquired immunity in rats that have eliminated intracranial gliosarcoma cells by the expression of herpes simplex virus-thymidine kinase gene and ganciclovir administration." Oncology. 54. 329-334 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Y.Iwadate, H.Namba, M.Tagawa, K.Takenaga, K.Sueyoshi, S.Sakiyama: "In vivo bystander effect in the intracranial model with rat glioma cells reflects the clonal difference of HSV-TK positive cells" Int J Oncology.

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1999-12-08  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi